Learning Laparoscopic Radical Hysterectomy: Are We Facing an Emerging Situation?
LACC trial
abdominal radical hysterectomy
cervical cancer
laparoscopic radical hysterectomy
learning curve
robotic radical hysterectomy
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
22 01 2023
22 01 2023
Historique:
received:
15
12
2022
revised:
12
01
2023
accepted:
19
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
Despite wide screening campaigns and early detection, cervical cancer remains the fourth most common cancer among women. Radical hysterectomy, whether by open, laparoscopic or by robotic-assisted techniques, is the mainstay treatment. However, for adequate surgical results and good oncological prognosis, a gynecological surgeon should be trained to perform those procedures. The learning curve of radical hysterectomy, especially by laparoscopy, is influenced by several factors. The LACC trial, the decrease in cervical cancer incidence and radical hysterectomy procedures have widely reduced the learning curve for surgeons. This article mainly discusses the learning curve of laparoscopic radical hysterectomy for cervical cancers, and how several factors are influencing it negatively, with the need to have medical authorities reset specific surgical training programs and allocate them to special oncological centers.
Identifiants
pubmed: 36767419
pii: ijerph20032053
doi: 10.3390/ijerph20032053
pmc: PMC9915887
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Front Oncol. 2020 Aug 28;10:1738
pubmed: 32984056
Int J Gynecol Cancer. 2011 Jul;21(5):930-5
pubmed: 21412161
J Minim Invasive Gynecol. 2021 Jan;28(1):117-123
pubmed: 32320800
J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S97
pubmed: 27679392
Curr Opin Obstet Gynecol. 2008 Feb;20(1):14-9
pubmed: 18197000
Afr J Med Med Sci. 2010 Dec;39(4):329-32
pubmed: 21736000
N Engl J Med. 2021 Apr 29;384(17):1669-1671
pubmed: 33913646
J Invest Surg. 2022 Jul;35(7):1602-1603
pubmed: 35549629
Obstet Gynecol Sci. 2015 Sep;58(5):377-84
pubmed: 26430662
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Obstet Gynecol Sci. 2018 Jul;61(4):468-476
pubmed: 30018901
J Reprod Infertil. 2017 Apr-Jun;18(2):261-263
pubmed: 28868252
Minim Invasive Ther Allied Technol. 2022 Jun;31(5):684-689
pubmed: 34651559
Gynecol Surg. 2010 Sep;7(3):253-258
pubmed: 20700514
Updates Surg. 2017 Dec;69(4):441-449
pubmed: 28918603
Expert Rev Anticancer Ther. 2010 Mar;10(3):451-60
pubmed: 20214525
Facts Views Vis Obgyn. 2021 Sep;13(3):231-239
pubmed: 34555877
Gynecol Obstet Fertil. 2015 May;43(5):348-55
pubmed: 25813433
BJOG. 2021 Dec;128(13):2213-2214
pubmed: 34402585
Int J Gynaecol Obstet. 2015 Feb;128(2):165-8
pubmed: 25444613
Clin Oncol (R Coll Radiol). 2008 Aug;20(6):395-400
pubmed: 18606356
Int J Environ Res Public Health. 2022 Oct 13;19(20):
pubmed: 36293758
Int J Surg. 2019 Aug;68:72-77
pubmed: 31220631
Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):219-23
pubmed: 22841654
BMC Cancer. 2020 Feb 24;20(1):152
pubmed: 32093687
Clin Epidemiol. 2021 Jun 01;13:407-416
pubmed: 34103999
Hum Fertil (Camb). 2018 Apr;21(1):35-38
pubmed: 28625095
Diagnostics (Basel). 2022 Nov 13;12(11):
pubmed: 36428831
Int J Gynecol Cancer. 2009 Nov;19(8):1459-64
pubmed: 20009907
J Gynecol Oncol. 2013 Oct;24(4):303-12
pubmed: 24167665
Asian J Surg. 2021 Jan;44(1):174-180
pubmed: 32467009
Cancer Res Treat. 2021 Jan;53(1):243-251
pubmed: 33070554
Lancet. 2022 Nov 05;400(10363):1607-1617
pubmed: 36328042
Int J Environ Res Public Health. 2022 Jun 09;19(12):
pubmed: 35742340
J Clin Med. 2022 Jun 10;11(12):
pubmed: 35743403
Curr Opin Oncol. 2022 Sep 1;34(5):473-489
pubmed: 35880461
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365
Gynecol Oncol. 2022 Mar;164(3):535-542
pubmed: 34969535